Skip to main content
. 2021 Mar 20;188(2):571–581. doi: 10.1007/s10549-021-06178-8

Fig. 2.

Fig. 2

Overall survival in patients systemically treated for a HER2 + , b HR + /HER2 + , c HR-/HER2 + ABC by incidence period of ABC diagnosis